Pegvaliase (2) – Palynziq®
Phenylketonuria; 12 to < 16 years
Characteristics
| Start date | 01.08.2026 |
|---|---|
| Resolution | 21.01.2027 – active procedure |
| INN | Pegvaliase |
| Brand name | Palynziq® |
| Pharm. company | BioMarin Deutschland GmbH |
| G-BA Procedure ID | D-1366 |
| Therapeutic area | Metabolic diseases Orphan |
| Reason for procedure | New therapeutic indication |
Associated procedures
| Pegvaliase (2) | Palynziq® | BioMarin Deutschland GmbH | Phenylketonuria; 12 to < 16 years | n.d. | active procedure Orphan | |
| Pegvaliase (1) | Palynziq® | BioMarin International Limited | Phenylketonuria | 435 | 100% Hint for non-quantifiable additional benefit Orphan |
<< List of all resolutions